Alteration of Bone Density, Microarchitecture, and Strength in Patients with Camurati–Engelmann Disease: Assessed by HR-pQCT

Authors:

Abstract
Camurati-Engelmann disease is a rare autosomal dominant skeletal dysplasia caused by mutations in the transforming growth factor-β1 (TGFB1) gene. In this study, we performed a retrospective review of patients with CED evaluated in Peking Union Medical College Hospital from November 30, 2000 to November 30, 2020. Data including demographic data, manifestations and examination results were characterized. Further, we assessed bone geometry, density, microarchitecture and estimated bone strength by High-resolution peripheral quantitative computed tomography (HR-pQCT). Results showed the median age at onset was 2.5 years. Common manifestations included pain in the lower limbs (94%, 17/18), abnormal gait (89%, 16/18), genu valgum (89%, 16/18), reduced subcutaneous fat (78%, 14/18), delayed puberty (73%, 8/11), muscle weakness (67%, 12/18), hearing loss (39%, 7/18), hepatosplenomegaly (39%, 7/18), exophthalmos or impaired vision or visual field defect (33%, 6/18), and anemia (33%, 7/18). 25% (4/16) of patients had short stature. Serum level of alkaline phosphatase (ALP) was elevated in 41% (7/17) of patients whereas beta-C-terminal telopeptide (β-CTX) was elevated in 91% of patients (10/11). Among 12 patients, Z-scores of 2 patients were greater than 2.5 at femur neck and Z-scores of 5 patients were lower than -2.5 at femur neck and/or lumbar spine. HR-pQCT results showed lower vBMD, altered bone microstructure and lower estimated bone strength at the distal radius and tibia in patients with CED compared to controls. Besides, Tt.vBMD and Ct.vBMD at the radius were negatively correlated with age in CED patients but positively correlated with age in controls. In conclusion, we reported the largest case series of CED in Chinese and characterized clinical features. Further, we used HR-pQCT to investigate bone microstructure at the distal radius and tibia in 9 patients with CED and demonstrated alteration of bone density, microstructure and strength for the first time.
Funding Information
  • National Key R&D Program of China (2018YFA 0800801)
  • Foundation for Innovative Research Groups of the National Natural Science Fund of China (81970757)
  • Foundation for Innovative Research Groups of the National Natural Science Fund of China (81970757)

This publication has 30 references indexed in Scilit: